Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering

Tissue Engineering - Part A

Volumn 15, Issue 8, 2009, Pages 2309-2313

  Kupcsik, Laszlo ^a,b   Alini, Mauro ^a   Stoddart, Martin J ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDS; CARTILAGE; CELL CULTURE; COLLAGEN; DEGRADATION; LIGAMENTS; PELLETIZING;

CARTILAGE TISSUE ENGINEERING; CHONDROCYTIC; CHONDROGENIC; CHONDROGENIC DIFFERENTIATION; CULTURE SYSTEMS; GLYCOSAMINOGLYCANS; HUMAN BONE MARROW; MARKER GENES; PROTEOGLYCANS; REAL TIME RT-PCR; TRANSFORMING GROWTH FACTORS;

TISSUE ENGINEERING;

AGGRECAN; AMINOCAPROIC ACID; COLLAGEN; COLLAGEN TYPE 10; COLLAGEN TYPE 2; FIBRIN; GLYCOSAMINOGLYCAN; PLASMIN; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE MARROW; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARTILAGE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME INHIBITION; FIBRIN CLOT; GENE EXPRESSION; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TISSUE ENGINEERING;

6-AMINOCAPROIC ACID; CARTILAGE; FIBRIN; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; HUMANS; PHENAZINES; PROTEIN PROCESSING, POST-TRANSLATIONAL; STAINING AND LABELING; SUBCELLULAR FRACTIONS; TISSUE ENGINEERING;

EID: 68749098305     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0400     Document Type: Article

References (12)

1. Uhlén, M., Björling, E., Agaton, C., Szigyarto, C.A.-K., Amini, B., Andersen, E., Andersson, A.C., Angelidou, P., Asplund, A., Asplund, C., Berglund, L., Bergström, K., Brumer, H., Cerjan, D., Ekström, M., Elobeid, A., Eriksson, C., Fagerberg, L., Falk, R., Fall, J., Forsberg, M., Björklund, M.G., Gumbel, K., Halimi, A., Hallin, I., Hamsten, C., Hansson, M., Hedhammar, M., Hercules, G., Kampf, C., Larsson, K., Lindskog, M., Lodewyckx, W., Lund, J., Lun-deberg, J., Magnusson, K., Malm, E., Nilsson, P., Odling, J., Oksvold, P., Olsson, I., Oster, E., Ottosson, J., Paavilainen, L., Persson, A., Rimini, R., Rockberg, J., Runeson, M., Si-vertsson, A., Sköllermo, A., Steen, J., Stenvall, M., Sterky, F., Stromberg, S., Sundberg, M., Tegel, H., Tourle, S., Wahlund, E., Waldén, A., Wan, J., Wernérus, H., Westberg, J., Wester, K., Wrethagen, U., Xu, L.L., Hober, S., and Pontén, F. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4, 1920, 2005.
2. Prentice, C.R. Basis of antifibrinolytic therapy. J Clin Pathol Suppl (R Coll Pathol) 14, 35, 1980.
3. Dessaint, J.P., Katz, S.P., and Waksman, B.H. Catheptic car-boxypeptidase B as a major component in "T-cell activating factor" of macrophages. J Immunopharmacol 1, 399, 1979.
4. Soter, N.A., Austen, K.F., and Gigli, I. Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system. J Immunol 114, 928, 1975.
5. Connelly, J.T., Vanderploeg, E.J., and Levenston, M.E. The influence of cyclic tension amplitude on chondrocyte matrix synthesis: experimental and finite element analyses. Biorheology 41, 377, 2004.
6. Huang, C.Y.C., Cheung, H.S., and Deitzer, M.A. Effects of fibrinolytic inhibitors on chondrogenesis of bone-marrow derived mesenchymal stem cells in fibrin gels. Biomech Model Mechanobiol 6, 5, 2007.
7. Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, V.M., and Yoo, J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238, 265, 1998.
8. Yoo, J.U., Barthel, T.S., Nishimura, K., Solchaga, L., Caplan, A.I., Goldberg, V.M., and Johnstone, B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80, 1745, 1998.
9. Labarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102, 344, 1980.
10. Farndale, R.W., Buttle, D.J., and Barrett, A.J. Improved quan-titation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883, 173, 1986.
11. Rasband, W.S. ImageJ. U.S. National Institutes of Health, Bethesda, Maryland, USA, 1997-2008. http://rsb.info.nih.gov/ij/.
12. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2005.